Cafom (FRA:CAA) Research & Development: €0.0 Mil (TTM As of Sep. 2025)

Cafom FRA:CAA +5.95% 68 Research & Development is €0.0 Mil as of Sep. 2025. GuruFocus rates FRA:CAA with a GF Score™ of 68/100 and a GF Value™ of €9.67 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cafom's Research & Development for the six months ended in Sep. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was €0.0 Mil.

Cafom (FRA:CAA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cafom Research & Development Related Terms

Cafom Research & Development Historical Data

* Premium members only.

The historical data trend for Cafom's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cafom Research & Development Chart

Cafom Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Research & Development

Get a 7-Day Free Trial

0.00

Cafom Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25
Research & Development	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

68GF Score

Cafom FRA:CAA

Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cafom Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Frequently Asked Questions Learn more about Research & Development →

What does a Research & Development of €0.0 Mil mean?

Cafom (FRA:CAA) has a Research & Development of €0.0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cafom and its competitors.

Is Cafom's Research & Development too high?

Cafom's current Research & Development is €0.0 Mil. Overall, Cafom has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Cafom's Research & Development compare to HD and LOW?

Cafom's Research & Development of €0.0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Research & Development for a Retail - Cyclical company?

A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Research & Development mean?

A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cafom and its competitors. Cafom's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cafom stock overvalued right now?

Based on GuruFocus' analysis, Cafom (FRA:CAA) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.67, compared to a current price of €13.35 — trading 38.1% above its estimated fair value. The current Research & Development is €0.0 Mil. Cafom's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Research & Development calculated?

Research & Development is calculated from a company's financial statements. For Cafom (FRA:CAA), the current Research & Development is €0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cafom (FRA:CAA) Overvalued in 2026?

Based on GuruFocus' analysis, Cafom stock appears to be overvalued. The current stock price of €13.35 is trading 38.1% above its estimated GF Value™ of €9.67. GuruFocus considers Cafom to be Significantly Overvalued.

Key valuation signals for FRA:CAA:

Research & Development: €0.0 Mil
GF Value™: €9.67 vs. price of €13.35 (38.1% above fair value)
GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the FRA:CAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.